Ilse Gijselinck wins Dr. Karel-Lodewijk Verleysen award

3 December 2016
The Belgian Royal Academy of Medicine has granted the Dr. Karel-Lodewijk Verleysen award to Ilse Gijselinck, postdoc at the VIB Department of Molecular Genetics (University of Antwerp).  The prize is awarded last Saterday, December 3. With a prize amount of 15,000 euros, the award recognizes Ilse’s groundbreaking medical research in the field of neurodegenerative brain diseases.

Frontotemporal Lobar Degeneration (FTLD) and Amyotrophic Lateral Sclerosis (ALS) are two fatal neurodegenerative diseases, often affecting people who are mid-career and raising a family (45-65 years). As there are no preventive or curative treatments available, scientific understanding of the neurodegenerative processes occurring in patients’ brains is essential. With her research, Ilse aims to further expand medical science’s understanding of the affected gene networks and biological processes in order to identify therapeutic targets that could delay or halt the diseases.
‘A culmination of my research’

The Dr. Karel-Lodewijk Verleysen award consists of 5,000 euros as a personal reward and 10,000 euros for the continuation of the scientific research. “This award is a great culmination of my research”, Ilse says. “Over the past 12 years, we have identified the three main genes for FTLD and ALS. I hope that the prize will help us continue and expand our research so that we can find therapies to help people with these hopeless diseases."